# Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

> **NCT01181570** · PHASE4 · COMPLETED · sponsor: **Innovaderm Research Inc.** · enrollment: 20 (actual)

## Conditions studied

- Psoriasis
- Sleep Apnea, Obstructive

## Interventions

- **DRUG:** Adalimumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01181570
- **Lead sponsor:** Innovaderm Research Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181570, "Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01181570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*